Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
16 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
GE HealthCare raised its full-year adjusted earnings outlook to $4.95–$5.05 a share from its prior outlook, citing healthy demand. Profit and revenue rose in the latest quarter.
RingCentral said Q3 subscription and total revenue exceeded the high end of guidance and reported record GAAP and non-GAAP operating margins. It raised fiscal 2026 expectations for subscription revenue, total revenue and free cash flow.
Danaher reported third-quarter core revenue growth of 5.5%, excluding respiratory revenue, and a nearly 30% adjusted operating profit margin. It raised full-year adjusted diluted EPS guidance to $8.57–$8.62 and expects fourth-quarter core revenue growth, excluding respiratory revenue, of 4%–5%.
Thermo Fisher reported Q3 revenue of $12.14 billion, up 9%, and adjusted EPS of $6.68, up 15%. It raised 2026 revenue guidance to $47.7–$48.2 billion and adjusted EPS guidance to $25.13–$25.43.
UnitedHealth raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share, from a previous range of $19.50 to $20. Third-quarter earnings were described as stronger than expected.
FIGS reported Q2 2026 net revenues of $197 million, up 29%, and raised its full-year revenue growth guidance to 20% from 14%–16%. The company also authorized a $100 million share buyback.
Inogen reported second-quarter revenue of $95.1 million, up 3% year over year, and adjusted EBITDA of $2.4 million, up 15%. The company lowered full-year 2026 revenue guidance to $355-$361 million and raised adjusted EBITDA guidance to $4 million.
Twilio reported Q2 revenue of $1.5 billion, with organic revenue growth of 17% year over year. It raised its full-year organic revenue growth target to 13–13.5% and reported revenue growth target to 18–18.5%.
Genpact reported Q2 2026 revenue of $1.343 billion, up 7.1% year over year, and said it expects at least 7% revenue growth in 2026. Advanced Technology Solutions revenue rose 24.1%, with the segment expected to grow at least 25% in 2026.
Arlo reported Q2 revenue of $156 million, up more than 20% year over year, and non-GAAP EPS of $0.28, up 65%. It raised full-year 2026 revenue and EPS guidance.
Haemonetics (NYSE: HAE ) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Haemonetics C
On Wednesday, Jabil (NYSE: JBL ) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Jabil Inc reported a strong finish to fiscal 2026 with Q4 revenue
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ) shares are trading higher on Tuesday as the company raises full-year 2026 revenue guidance, bucking a -0.8% slide in the Healthcare sector even as the S&P 500 is down 0.10%. The move reads as company-specific strength rather than a broad risk-on tape, with market breadth on
Academy Sports reported second-quarter sales of $1.6 billion, up 3%, with comps down 0.4%, and raised full-year EPS guidance to $6.05 to $6.45 while reaffirming sales growth of 3% to 5%.
Zscaler said fourth-quarter annual recurring revenue rose 25% and non-GAAP operating margin reached 24.3%, while Security for AI bookings increased more than 50% sequentially.
DocuSign reported Q2 revenue of $876 million, up 9% year over year, with a 32% operating margin and about $300 million in free cash flow. It also raised fiscal 2027 ARR guidance and said IAM now accounts for 15.1% of total ARR.